Lantern Pharma Inc. Quarterly Current Ratio in % from Q1 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Lantern Pharma Inc. quarterly Current Ratio history and growth rate from Q1 2021 to Q3 2024.
  • Lantern Pharma Inc. Current Ratio for the quarter ending September 30, 2024 was 998 %, a 49% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 998 -957 -49% Sep 30, 2024
Q2 2024 1.23K -705 -36.5% Jun 30, 2024
Q1 2024 1.52K -198 -11.5% Mar 31, 2024
Q4 2023 1.83K +59.2 +3.33% Dec 31, 2023
Q3 2023 1.96K +18.9 +0.97% Sep 30, 2023
Q2 2023 1.93K -329 -14.5% Jun 30, 2023
Q1 2023 1.72K -1.31K -43.1% Mar 31, 2023
Q4 2022 1.77K -2.43K -57.8% Dec 31, 2022
Q3 2022 1.94K -2.65K -57.8% Sep 30, 2022
Q2 2022 2.26K -2.13K -48.5% Jun 30, 2022
Q1 2022 3.03K -474 -13.5% Mar 31, 2022
Q4 2021 4.2K Dec 31, 2021
Q3 2021 4.59K Sep 30, 2021
Q2 2021 4.39K Jun 30, 2021
Q1 2021 3.5K Mar 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.